Microsoft passes Apple to become the world’s most valuable company

Technology

In this article

Dado Ruvic | Reuters

Microsoft passed Apple in market cap on Friday, making it the world’s most valuable publicly-traded company, after Apple missed earnings expectations on Thursday.

As of 10:30 a.m. ET Microsoft had a market cap of $2.45 trillion while Apple’s stood at about $2.41 trillion.

Apple reported revenue that fell short of Wall Street expectations during the company’s fiscal fourth-quarter on Thursday, a result of supply chain constraints. CEO Tim Cook told CNBC’s Josh Lipton the revenue shortfall is estimated at $6 billion, but he expects worse supply chain issues in the December quarter.

iPhone sales at the company were up 47% year-over-year but also fell short of analyst expectations. The company’s fourth-quarter only included a few days of iPhone 13 sales.

Microsoft beat revenue expectations during its fiscal first quarter, which climbed about 22% year-over-year. That was the fastest growth since 2018, CNBC previously reported.

Apple was the first company to reach a $1 trillion and $2 trillion market cap. It became the world’s most valuable publicly-traded company when it surpassed state oil giant Saudi Aramco in market cap last year.

Microsoft last surpassed Apple in market cap in 2020 as the pandemic wreaked havoc on supply chains. It first closed above a $2 trillion market cap in June after revealing the first major update to Windows in more than five years.

At 10:30 a.m. ET, Microsoft’s stock was up almost 47% year to date, while Apple’s was up about 11%.

This news is developing. Please check back for updates.

Products You May Like

Articles You May Like

Six trades that NHL teams should make after roster freeze, including Provorov, Gourde, Boeser
Bank of England keeps ‘gradual’ cut prospects alive as interest rate held
Tesla reverses losses to turn higher in a volatile week for the EV stock
California’s $2,000 electric bike vouchers came and went in just minutes
Critical EV battery materials face a supply crunch by 2030

Leave a Reply

Your email address will not be published. Required fields are marked *